Mamtha Balla: Valuable information for oncologists and providers dealing with immunocompromised patients
Mamtha Balla, Transplant Oncology-ID fellow, MD Anderson Cancer Center, shared the following on X:
Thank you, IOTOX, for accepting our poster on TIL therapy and the challenges involved in treating a COVID-19 patient who underwent TIL therapy. This information will be valuable for oncologists and providers dealing with immunocompromised patients. I look forward to seeing everyone in Houston during the poster presentation at the IOTOX symposium on November 6th at 5 PM!”
Supriya Peshin reposted that tweet on X, adding:
“Thank you Mamtha B for all your support and guidance.”
Supriya Peshin is an Internal Medicine Resident at Ballad Health. She previously completed a visiting residency in Hematology and Oncology at the University of Arizona Health Sciences. She was also an Internal Medicine Resident at the East Tennessee State University James H. Quillen College of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023